Duke Cancer Institute - Sarcoma Research

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Leukemia

Studies at this site

• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling